The PSY-SIM Model: Using Real-World Data to Inform Health Care Policy for Individuals With Chronic Psychotic Disorders
Schizophrenia Bulletin · 2024
DOI: 10.1093/schbul/sbad175 ↗Kurz gefasst
Fachartikel in der Zeitschrift Schizophrenia Bulletin, 2024. Verfasst von Claire de Oliveira und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Mental Health Policy Research and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, On…. Hauptthemen laut MEDLINE: Psychotic Disorders, Smoking Cessation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ontario Ministries of Health and Long-term Care, Canadian Community Health Survey.
Abstract (Originalsprache)
Background and Hypothesis Few microsimulation models have been developed for chronic psychotic disorders, severe and disabling mental disorders associated with poor medical and psychiatric outcomes, and high costs of care. The objective of this work was to develop a microsimulation model for individuals with chronic psychotic disorders and to use the model to examine the impact of a smoking cessation initiative on patient outcomes. Study Design Using health records and survey data from Ontario, Canada, the PSY-SIM model was developed to simulate health and cost outcomes of individuals with chronic psychotic disorders. The model was then used to examine the impact of the Smoking Treatment for Ontario Patients (STOP) program from Ontario on the development of chronic conditions, life expectancy, quality of life, and lifetime health care costs. Study Results Individuals with chronic psychotic disorders had a lifetime risk of 63% for congestive heart failure and roughly 50% for respiratory disease, cancer and diabetes, and a life expectancy of 76 years. The model suggests the STOP program can reduce morbidity and lead to survival and quality of life gains with modest increases in health care costs. At a long-term quit rate of 4.4%, the incremental cost-effectiveness ratio of the STOP program was $41,936/QALY compared with status quo. Conclusions Smoking cessation initiatives among individuals with chronic psychotic disorders can be cost-effective. These findings will be relevant for decision-makers and clinicians looking to improving health outcomes among this patient population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Mental Health Policy Research and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
- ICES, Toronto, Ontario, Canada.
- Institute of Health Policy, Management, and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
- Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada.
- Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Claire de Oliveira, Joyce Mason, Tomisin Iwajomo, Frances Simbulan, Paul Kurdyak, Petros Pechlivanoglou
Förderung
- Ontario Ministries of Health and Long-term Care
- Canadian Community Health Survey
Zitieren
APA
de Oliveira, C., Mason, J., Luu, L., Iwajomo, T., Simbulan, F., Kurdyak, P., & Pechlivanoglou, P. (2024). The PSY-SIM Model: Using Real-World Data to Inform Health Care Policy for Individuals With Chronic Psychotic Disorders. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbad175
Vancouver
de Oliveira C, Mason J, Luu L, Iwajomo T, Simbulan F, Kurdyak P, et al. The PSY-SIM Model: Using Real-World Data to Inform Health Care Policy for Individuals With Chronic Psychotic Disorders. Schizophrenia Bulletin. 2024. doi:10.1093/schbul/sbad175
BibTeX
@article{deOliveira2024,
author = {de Oliveira, Claire and Mason, Joyce and Luu, Linda and Iwajomo, Tomisin and Simbulan, Frances and Kurdyak, Paul and Pechlivanoglou, Petros},
title = {The PSY-SIM Model: Using Real-World Data to Inform Health Care Policy for Individuals With Chronic Psychotic Disorders},
journal = {Schizophrenia Bulletin},
year = {2024},
doi = {10.1093/schbul/sbad175}
}
EUVIMED